|
2023-08-17 |
2023-08-16 |
S
Sale
|
CARLSON CAPITAL L P
Large shareholder
|
1,000
-0.0%
0.39
USD 392
|
1,000
-0.0%
|
0.39
|
USD 392
|
|
|
2023-08-17 |
2023-08-15 |
S
Sale
|
CARLSON CAPITAL L P
Large shareholder
|
215,000
-4.1%
0.44
USD 94,041
|
215,000
-4.1%
|
0.44
|
USD 94,041
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
MILLS ROBERT S
Non-Executive Director
|
40,000
+250.3%
0.25
USD 10,000
|
40,000
+250.3%
|
0.25
|
USD 10,000
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Mikhak Zamaneh
Chief Medical Officer
Officer
|
120,000
+800.0%
0.25
USD 30,000
|
120,000
+800.0%
|
0.25
|
USD 30,000
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
20,000
+125.0%
0.25
USD 5,000
|
20,000
+125.0%
|
0.25
|
USD 5,000
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
COLEMAN KIRK ALLEN
Chief Financial Officer
Officer
|
20,000
+127.6%
0.25
USD 5,000
|
20,000
+127.6%
|
0.25
|
USD 5,000
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Weisman Harlan F
President and CEO
Executive Director
|
600,000
+279.6%
0.25
USD 150,000
|
600,000
+279.6%
|
0.25
|
USD 150,000
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Roberts Brandi
Non-Executive Director
|
20,000
+inf%
0.25
USD 5,000
|
20,000
+inf%
|
0.25
|
USD 5,000
|
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
Weisman Harlan F
President and CEO
Executive Director
|
150,000
+232.1%
0.88
USD 131,835
|
150,000
+232.1%
|
0.88
|
USD 131,835
|
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
13,000
+433.3%
0.80
USD 10,433
|
13,000
+433.3%
|
0.80
|
USD 10,433
|
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
Mikhak Zamaneh
Chief Medical Officer
Officer
|
15,000
+inf%
0.82
USD 12,300
|
15,000
+inf%
|
0.82
|
USD 12,300
|
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
COLEMAN KIRK ALLEN
Chief Financial Officer
Officer
|
12,000
+326.5%
0.79
USD 9,457
|
12,000
+326.5%
|
0.79
|
USD 9,457
|
|
|
2022-12-19 |
2022-12-15 |
B
Purchase
|
Weisman Harlan F
President and CEO
Executive Director
|
50,000
+342.1%
1.06
USD 53,000
|
50,000
+342.1%
|
1.06
|
USD 53,000
|
|
|
2022-11-23 |
2022-11-22 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
43,470
+43.5%
1.15
USD 49,991
|
43,470
+43.5%
|
1.15
|
USD 49,991
|
|
|
2022-05-20 |
2022-05-20 |
B
Purchase
|
Weisman Harlan F
Non-Executive Director
|
4,615
+46.2%
5.50
USD 25,383
|
4,615
+46.2%
|
5.50
|
USD 25,383
|
|
|
2022-05-20 |
2022-05-18 |
B
Purchase
|
Weisman Harlan F
Non-Executive Director
|
2,500
+33.3%
5.12
USD 12,800
|
2,500
+33.3%
|
5.12
|
USD 12,800
|
|
|
2022-05-17 |
2022-05-17 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
24,600
+28.9%
5.08
USD 124,968
|
24,600
+28.9%
|
5.08
|
USD 124,968
|
|
|
2022-05-17 |
2022-05-17 |
B
Purchase
|
COLEMAN KIRK ALLEN
Chief Financial Officer
Officer
|
425
+13.1%
4.83
USD 2,053
|
425
+13.1%
|
4.83
|
USD 2,053
|
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
Mattes Glenn R.
President and CEO
Executive Director
|
16,000
+80.0%
4.78
USD 76,480
|
16,000
+80.0%
|
4.78
|
USD 76,480
|
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
3,000
+19.1%
4.54
USD 13,620
|
3,000
+19.1%
|
4.54
|
USD 13,620
|
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
Weisman Harlan F
Non-Executive Director
|
2,500
+50.0%
4.74
USD 11,850
|
2,500
+50.0%
|
4.74
|
USD 11,850
|
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
85,000
+inf%
4.86
USD 413,100
|
85,000
+inf%
|
4.86
|
USD 413,100
|
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
COLEMAN KIRK ALLEN
Chief Financial Officer
Officer
|
1,250
+62.5%
4.40
USD 5,500
|
1,250
+62.5%
|
4.40
|
USD 5,500
|
|
|
2022-04-04 |
2022-04-04 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
42,000
+8.4%
6.89
USD 289,380
|
42,000
+8.4%
|
6.89
|
USD 289,380
|
|
|
2022-04-04 |
2022-04-04 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
500,000
+inf%
6.43
USD 3,215,000
|
500,000
+inf%
|
6.43
|
USD 3,215,000
|
|
|
2021-05-19 |
2021-05-19 |
B
Purchase
|
Fairbairn Malcolm
Non-Executive Director
|
10,000
+inf%
8.95
USD 89,500
|
10,000
+inf%
|
8.95
|
USD 89,500
|
|
|
2021-05-19 |
2021-05-18 |
B
Purchase
|
THURMAN RANDY H
Non-Executive Director
|
1,050
+inf%
9.40
USD 9,870
|
1,050
+inf%
|
9.40
|
USD 9,870
|
|
|
2021-03-30 |
2021-03-26 |
S
Sale
|
Lung Therapeutics, Inc.
Large shareholder
|
715,000
-24.2%
14.00
USD 10,010,000
|
715,000
-24.2%
|
14.00
|
USD 10,010,000
|
|
|
2021-03-17 |
2021-03-15 |
S
Sale
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
20,006
-56.0%
16.85
USD 337,101
|
20,006
-56.0%
|
16.85
|
USD 337,101
|
|
|
2021-03-17 |
2021-03-15 |
PS
Planned sale
|
Mattes Glenn R.
President and CEO
Executive Director
|
50,000
-83.3%
17.04
USD 852,000
|
50,000
-83.3%
|
17.04
|
USD 852,000
|
|
|
2021-03-17 |
2021-03-15 |
PS
Planned sale
|
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
Officer
|
5,000
-83.3%
17.05
USD 85,250
|
5,000
-83.3%
|
17.05
|
USD 85,250
|
|
|
2021-02-18 |
2021-02-16 |
PS
Planned sale
|
Mattes Glenn R.
President and CEO
Executive Director
|
40,000
-80.0%
16.82
USD 672,800
|
40,000
-80.0%
|
16.82
|
USD 672,800
|
|
|
2021-02-18 |
2021-02-16 |
PS
Planned sale
|
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
Officer
|
5,000
-83.3%
16.82
USD 84,100
|
5,000
-83.3%
|
16.82
|
USD 84,100
|
|
|
2021-02-12 |
2021-02-10 |
PS
Planned sale
|
MILLS ROBERT S
Non-Executive Director
|
700
-4.2%
20.16
USD 14,112
|
700
-4.2%
|
20.16
|
USD 14,112
|
|
|
2021-01-20 |
2021-01-20 |
PS
Planned sale
|
MILLS ROBERT S
Non-Executive Director
|
12,600
-44.1%
20.20
USD 254,520
|
12,600
-44.1%
|
20.20
|
USD 254,520
|
|
|
2021-01-20 |
2021-01-19 |
PS
Planned sale
|
MILLS ROBERT S
Non-Executive Director
|
55,100
-77.5%
19.56
USD 1,077,756
|
55,100
-77.5%
|
19.56
|
USD 1,077,756
|
|
|
2021-01-20 |
2021-01-15 |
PS
Planned sale
|
Mattes Glenn R.
President and CEO
Executive Director
|
40,000
-80.0%
17.51
USD 700,400
|
40,000
-80.0%
|
17.51
|
USD 700,400
|
|
|
2021-01-20 |
2021-01-15 |
PS
Planned sale
|
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
Officer
|
5,000
-83.3%
17.50
USD 87,500
|
5,000
-83.3%
|
17.50
|
USD 87,500
|
|
|
2020-12-29 |
2020-12-23 |
PS
Planned sale
|
Mattes Glenn R.
President and CEO
Executive Director
|
30,000
-75.0%
15.33
USD 459,900
|
30,000
-75.0%
|
15.33
|
USD 459,900
|
|
|
2020-12-29 |
2020-12-23 |
PS
Planned sale
|
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
Officer
|
10,000
-90.9%
15.24
USD 152,400
|
10,000
-90.9%
|
15.24
|
USD 152,400
|
|
|
2020-12-15 |
2020-12-11 |
S
Sale
|
MILLS ROBERT S
Non-Executive Director
|
22,794
-58.8%
14.58
USD 332,337
|
22,794
-58.8%
|
14.58
|
USD 332,337
|
|
|
2020-12-09 |
2020-12-07 |
S
Sale
|
WINDSOR JAMES BRIAN
Chief Science Officer
Executive Director
|
25,000
-83.3%
15.80
USD 395,000
|
25,000
-83.3%
|
15.80
|
USD 395,000
|
|
|
2020-12-08 |
2020-12-04 |
S
Sale
|
Lung Therapeutics, Inc.
Large shareholder
|
250,000
-7.8%
13.86
USD 3,465,000
|
250,000
-7.8%
|
13.86
|
USD 3,465,000
|
|
|
2020-12-08 |
2020-12-04 |
S
Sale
|
Lung Therapeutics, Inc.
Large shareholder
|
300,000
-8.6%
13.86
USD 4,158,000
|
300,000
-8.6%
|
13.86
|
USD 4,158,000
|
|
|
2020-12-08 |
2020-12-04 |
S
Sale
|
Lung Therapeutics, Inc.
Large shareholder
|
500,000
-12.5%
13.85
USD 6,925,000
|
500,000
-12.5%
|
13.85
|
USD 6,925,000
|
|
|
2020-11-24 |
2020-11-24 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
5,000
+5.3%
15.13
USD 75,656
|
5,000
+5.3%
|
15.13
|
USD 75,656
|
|
|
2020-11-13 |
2020-11-13 |
S
Sale
|
THURMAN RANDY H
Non-Executive Director
|
5,000
-100.0%
17.17
USD 85,865
|
5,000
-100.0%
|
17.17
|
USD 85,865
|
|
|
2020-11-13 |
2020-11-12 |
S
Sale
|
Fairbairn Malcolm
Non-Executive Director
|
11,669
-100.0%
15.97
USD 186,307
|
11,669
-100.0%
|
15.97
|
USD 186,307
|
|
|
2020-11-13 |
2020-11-11 |
S
Sale
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
15,722
-100.0%
15.76
USD 247,732
|
15,722
-100.0%
|
15.76
|
USD 247,732
|
|
|
2020-11-13 |
2020-11-11 |
S
Sale
|
THURMAN RANDY H
Non-Executive Director
|
34,504
-87.3%
15.91
USD 548,890
|
34,504
-87.3%
|
15.91
|
USD 548,890
|
|
|
2020-11-13 |
2020-11-11 |
S
Sale
|
Fairbairn Malcolm
Non-Executive Director
|
63,331
-84.4%
15.93
USD 1,008,926
|
63,331
-84.4%
|
15.93
|
USD 1,008,926
|
|
|
2020-11-13 |
2020-11-10 |
S
Sale
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
21,278
-100.0%
15.14
USD 322,106
|
21,278
-100.0%
|
15.14
|
USD 322,106
|
|
|
2020-11-13 |
2020-11-10 |
S
Sale
|
Mattes Glenn R.
President and CEO
Executive Director
|
108,830
-91.6%
15.00
USD 1,631,906
|
108,830
-91.6%
|
15.00
|
USD 1,631,906
|
|
|
2020-11-13 |
2020-11-10 |
S
Sale
|
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
Officer
|
15,000
-93.8%
15.12
USD 226,755
|
15,000
-93.8%
|
15.12
|
USD 226,755
|
|
|
2021-01-20 |
2020-09-25 |
S
Sale
|
Mattes Glenn R.
President and CEO
Executive Director
|
3,000
-30.0%
17.00
USD 51,000
|
3,000
-30.0%
|
17.00
|
USD 51,000
|
|
|
2020-05-26 |
2020-05-26 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
20,000
+26.7%
5.08
USD 101,600
|
20,000
+26.7%
|
5.08
|
USD 101,600
|
|
|
2020-04-17 |
2020-04-15 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
5,581
+8.0%
4.72
USD 26,342
|
5,581
+8.0%
|
4.72
|
USD 26,342
|
|
|
2020-04-06 |
2020-04-06 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
6,252
+9.9%
4.24
USD 26,508
|
6,252
+9.9%
|
4.24
|
USD 26,508
|
|
|
2020-04-06 |
2020-04-03 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
16,748
+36.1%
3.97
USD 66,490
|
16,748
+36.1%
|
3.97
|
USD 66,490
|
|
|
2020-04-06 |
2020-04-02 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
500
+1.1%
3.75
USD 1,875
|
500
+1.1%
|
3.75
|
USD 1,875
|
|
|
2019-10-29 |
2019-10-25 |
B
Purchase
|
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
|
1,000
+inf%
5.00
USD 5,000
|
1,000
+inf%
|
5.00
|
USD 5,000
|
|
|
2019-10-29 |
2019-10-25 |
B
Purchase
|
MILLS ROBERT S
|
5,000
+inf%
5.00
USD 25,000
|
5,000
+inf%
|
5.00
|
USD 25,000
|
|
|
2019-10-29 |
2019-10-25 |
B
Purchase
|
THURMAN RANDY H
|
5,000
+inf%
5.00
USD 25,000
|
5,000
+inf%
|
5.00
|
USD 25,000
|
|
|
2019-10-29 |
2019-10-25 |
B
Purchase
|
Mattes Glenn R.
President and CEO
Executive Director
|
10,000
+inf%
5.00
USD 50,000
|
10,000
+inf%
|
5.00
|
USD 50,000
|
|
|
2019-10-29 |
2019-10-25 |
B
Purchase
|
Weisman Harlan F
|
5,000
+inf%
5.00
USD 25,000
|
5,000
+inf%
|
5.00
|
USD 25,000
|
|
|
2019-10-29 |
2019-10-25 |
B
Purchase
|
WINDSOR JAMES BRIAN
Chief Science Officer
Executive Director
|
5,000
+inf%
5.00
USD 25,000
|
5,000
+inf%
|
5.00
|
USD 25,000
|
|
|
2019-10-29 |
2019-10-25 |
B
Purchase
|
Fletcher Aaron G.L.
|
2,000
+inf%
5.00
USD 10,000
|
2,000
+inf%
|
5.00
|
USD 10,000
|
|
